US EditionPublished • loading... • Updated
Rampart Appoints Gary Burbach as Chairman of the Board
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Endovascular TodayReposted by 
Cardiac Interventions Today
Cardiac Interventions TodayRampart Appoints Gary Burbach as Chairman of the Board
February 4, 2026—Rampart, an Alabama-based medical device company focused on interventional radiation safety, announced the appointment of Gerhard (Gary) F. Burbach as Chairman of its Board of Directors. Rampart, which is an Alabama-based developer of barrier-based radiation protection, recently announced the SECURE clinical program, a coordinated series of clinical studies spanning multiple interventional specialties to evaluate the use of Ramp…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
